FDA Approved: SAXENDA — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA has approved a supplemental application for Saxenda (liraglutide) by Novo Nordisk, likely resulting in changes to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SAXENDA (liraglutide)

Snippet

SUPPL AP for SAXENDA (LIRAGLUTIDE)